trending Market Intelligence /marketintelligence/en/news-insights/trending/sJ9SeBkA_qp1clZqAObYiA2 content esgSubNav
In This List

Minerva Neurosciences appoints president, directors

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Minerva Neurosciences appoints president, directors

Minerva Neurosciences Inc. appointed Rick Russell as president of the company.

The appointment follows CEO Remy Luthringer's resignation as the president of the company.

Russell was most recently the president and CEO of Ares Allergy Holdings Inc., which is now the global biopharmaceutical company Stallergenes Greer PLC.

Separately, Minerva Neurosciences appointed William Doyle and Hans Hasler as directors of the company.

Doyle is the executive chairman of NovoCure Ltd., a commercial stage oncology company.

Hasler is the founder and CEO of Vicarius Pharma AG.